Results 121–140 of 1306 for speaker:Nick Ainger

[Mrs. Janet Dean in the Chair] — Pulmonary Arterial Hypertension (2 Apr 2008)

Nick Ainger: I wish to declare an interest—I am a trustee of the Pulmonary Hypertension Association UK—which is listed in the Register of Members' Interests. I am grateful for the opportunity to bring to the House's attention the grave concerns of expert clinicians, patients and their advocates about the preliminary recommendations in the National Institute for Health and Clinical Excellence appraisal...

[Mrs. Janet Dean in the Chair] — Pulmonary Arterial Hypertension (2 Apr 2008)

Nick Ainger: I agree totally, and I will make that point in greater detail later. In my view, it is a key factor that the appraisal committee, sadly, did not take into account.

[Mrs. Janet Dean in the Chair] — Pulmonary Arterial Hypertension (2 Apr 2008)

Nick Ainger: That is an interesting way of looking at it, but we must remember that drugs cost many millions of pounds to develop. I shall touch on ultra-orphan drugs, which include the drugs that we are discussing. NICE and the Department of Health should consider such drugs differently, and perhaps even support their production, so that people with rare conditions such as PAH are not prevented by the...

[Mrs. Janet Dean in the Chair] — Pulmonary Arterial Hypertension (2 Apr 2008)

Nick Ainger: I am well aware, as I am sure NICE is, that the drugs are used universally for the treatment of PAH. I am also aware that the cost of prostacyclins in the United States eight years ago was between one eighth and one tenth of the price in this country. There was a huge difference in price. Epoprostenol—its brand name is Flolan—which is manufactured in GlaxoSmithKline's plant in Dartford in...

[Mrs. Janet Dean in the Chair] — Pulmonary Arterial Hypertension (2 Apr 2008)

Nick Ainger: I do not know whether my hon. Friend's friend uses prostacyclin, but if prostacyclins are not available to clinicians to prescribe, there is no question but that the quality of life and the condition of PAH patients will decline dramatically. Their care, whether it is delivered at home or in hospital, will increase substantially, so there will be an enormous increase in the resources needed...

[Mrs. Janet Dean in the Chair] — Pulmonary Arterial Hypertension (2 Apr 2008)

Nick Ainger: That is the dramatic difference that the treatment can make to people's lives. Not only does it improve the quality of their life, but it keeps them alive. That is what has shocked those expert clinicians, who are world leaders in the treatment of the condition: NICE, without proposing an alternative, has suggested that the drugs be withdrawn.

[Mrs. Janet Dean in the Chair] — Pulmonary Arterial Hypertension (2 Apr 2008)

Nick Ainger: Indeed. I think that I have already made that point to the Minister. I have great sympathy with her in this case, however, because so far, it has nothing to do with the Department of Health; it is purely a preliminary recommendation by the NICE appraisal committee. The Minister must be aware that if the decision is confirmed, it may well—returning to the point that I made to my hon. Friend...

[Mrs. Janet Dean in the Chair] — Pulmonary Arterial Hypertension (2 Apr 2008)

Nick Ainger: I do not care whether negotiations are national, international, universal or whatever. The important thing is that they are ultra-orphan drugs that are used on a very small number of patients. That is the only difference. The things work. There is no question about the clinical efficacy of the drugs; it is purely about their unit costs. If that is the issue, we need to address it nationally,...

[Mrs. Janet Dean in the Chair] — Pulmonary Arterial Hypertension (2 Apr 2008)

Nick Ainger: Circumstances have changed since 1999-2000. Nevertheless, there is no question but that at the time the arrangement saved the national health service about £120,000 on that one patient, compared with the price that it would have paid the following year. The situation illustrates that throughout the world, different prices are charged for the same product. The irony was that we imported from...

Business of the House: Welsh Affairs (28 Feb 2008)

Nick Ainger: I shall begin by congratulating my right hon. Friend the Member for Neath (Mr. Hain), although he is not in his place at the moment, on an excellent speech. I add my words to those of many Members on both sides of the House about the service that he has given to Wales and Northern Ireland, and to the people of the United Kingdom when he was Secretary of State for Work and Pensions. He...

Business of the House: Welsh Affairs (28 Feb 2008)

Nick Ainger: I refer specifically to my own constituency, where the fall in unemployment—according to the latest Library figures and the claimant count figures—makes us 11th out of 646 constituencies. We have seen tremendous improvement on unemployment and employment, and one reason has been the clear success in my constituency of objective 1 funding—now convergence funding. The county council, the...

Business of the House: Welsh Affairs (28 Feb 2008)

Nick Ainger: Absolutely, and I agree that they ought seriously to reconsider. Feed-in tariffs are a way to incentivise individuals to invest in renewables and give a faster return on investment.

Business of the House: Welsh Affairs (28 Feb 2008)

Nick Ainger: I do not argue with the hon. Gentleman on that point. Let me turn to energy prices and their impact on my constituency, and the wider issue of fuel poverty. In 2004, Brent crude cost $30 a barrel, but today it costs just under $100 a barrel. That has affected more than just our industry. Given that the price of oil has more than doubled, it is remarkable how resilient our economy has been,...

Oral Answers to Questions — Wales: HMRC and DWP Offices (27 Feb 2008)

Nick Ainger: My hon. Friend will be aware that his office has been dealing with the matter for the past 12 months. One of the key issues has been the principle of co-location and joined-up government. The Treasury needs further pressure to consider seriously co-location and joined-up government with other Departments, including Welsh Assembly Departments, as well as with the NHS and even the private...

Public Bill Committee: Pensions Bill: Schedule 8 (19 Feb 2008)

Nick Ainger: I want to echo the praise that has been poured not just on the Minister for Pensions Reform, my hon. and learned Friend the Member for North Warwickshire, but also on the previous Secretary of State, my right hon. Friend the Member for Neath. Also, while individuals have been named, it is worth recalling the catalyst of the change. That was the bankruptcy of Allied Steel and Wire in Cardiff...

Written Answers — Transport: Pollution (18 Feb 2008)

Nick Ainger: To ask the Secretary of State for Transport when she expects the Government to ratify the (a) convention on hazardous and noxious substances 1996, (b) convention on oil pollution preparedness and co-operation/hazardous and noxious substances 2000, (c) anti-fouling convention and (d) ballast and water management convention; and if she will make a statement.

Public Bill Committee: Pensions Bill: Clause 62 (5 Feb 2008)

Nick Ainger: May I urge my hon. Friend the Minister to look at the amendments? There is genuine feeling about them, particularly bearing in mind the experience of similar funds throughout the world that do not  appear to have a problem with signing up to the principles. Perhaps we could reconsider the matter and return to it on Report. Colleagues on both sides of the House feel strongly about including...

Public Bill Committee: Pensions Bill: Clause 62 (5 Feb 2008)

Nick Ainger: I will speak to amendment No. 159 tabled in my name, which, as the hon. Member for Rochdale has indicated, is in line with his amendment. The aim of my amendment is to require the authority to be a responsible investor and to take environmental, social and corporate governance issues into account in its investment decisions. It is sad that we still need to argue and make the case for ethical...

Public Bill Committee: Pensions Bill: Clause 52 (31 Jan 2008)

Nick Ainger: I want to speak briefly about how members of the members’ panel are to be selected. I have been briefed by UNITE, which is not the organisation comprising the Transport and General Workers Union and Amicus. This UNITE got its name a lot earlier. It represents BT and Post Office pensioners and has existed for several of decades. It is in negotiations with Unite, the trade union, about the...

Written Answers — Defence: Departmental Land (28 Jan 2008)

Nick Ainger: To ask the Secretary of State for Defence for what reasons his Department transferred 50 acres of land at East Blockhouse, Augle, Pembrokeshire to QinetiQ on 27 March 2002; how much was received by his Department for the land; and what covenants (a) existed and (b) were placed on the land at the time of the transfer.


<< < 1 2 3 4 5 6 7 8 9 10 > >>

Create an alert

Advanced search

Find this exact word or phrase

You can also do this from the main search box by putting exact words in quotes: like "cycling" or "hutton report"

By default, we show words related to your search term, like “cycle” and “cycles” in a search for cycling. Putting the word in quotes, like "cycling", will stop this.

Excluding these words

You can also do this from the main search box by putting a minus sign before words you don’t want: like hunting -fox

We also support a bunch of boolean search modifiers, like AND and NEAR, for precise searching.

Date range

to

You can give a start date, an end date, or both to restrict results to a particular date range. A missing end date implies the current date, and a missing start date implies the oldest date we have in the system. Dates can be entered in any format you wish, e.g. 3rd March 2007 or 17/10/1989

Person

Enter a name here to restrict results to contributions only by that person.

Section

Restrict results to a particular parliament or assembly that we cover (e.g. the Scottish Parliament), or a particular type of data within an institution, such as Commons Written Answers.

Column

If you know the actual Hansard column number of the information you are interested in (perhaps you’re looking up a paper reference), you can restrict results to that; you can also use column:123 in the main search box.